 | • レポートコード：MRC2012B0929 • 出版社/出版日：GlobalInfoResearch / 2020年12月24日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、108ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、眼科治療の世界市場を広く調査・分析し、今後の市場展望をまとめております。眼科治療の種類別市場規模（ジェル、アイソリューション、カプセル＆錠剤、点眼薬、軟膏）、用途別市場規模（病院、小売薬局）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Allergan、Regeneron、Valeant、Aerie Pharmaceuticals、Novartis、Pfizer、Santen Pharmaceutical、Genentech、Bayer、Takeda、 ・地域別グローバル市場分析 2015年-2020年 ・眼科治療の北米市場（アメリカ、カナダ、メキシコ） ・眼科治療のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・眼科治療のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・眼科治療の南米市場（ブラジル、アルゼンチン） ・眼科治療の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：ジェル、アイソリューション、カプセル＆錠剤、点眼薬、軟膏 ・用途別分析：病院、小売薬局 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The global Ophthalmology Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Ophthalmology Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Ophthalmology Treatment market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Ophthalmology Treatment market has been segmented into:
Gels
Eye Solutions
Capsules & Tablets
Eye Drops
Ointments
By Application, Ophthalmology Treatment has been segmented into:
Hospital
Retail Pharmacy
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Ophthalmology Treatment market presented in the report. This section sheds light on the sales growth of different regional and country-level Ophthalmology Treatment markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Ophthalmology Treatment market.
The report offers in-depth assessment of the growth and other aspects of the Ophthalmology Treatment market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Ophthalmology Treatment Market Share Analysis
Ophthalmology Treatment competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Ophthalmology Treatment sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Ophthalmology Treatment sales, revenue and market share for each player covered in this report.
The major players covered in Ophthalmology Treatment are:
Allergan
Regeneron
Valeant
Aerie Pharmaceuticals
Novartis
Pfizer
Santen Pharmaceutical
Genentech
Bayer
Takeda
Table of Contents
1 Ophthalmology Treatment Market Overview
1.1 Product Overview and Scope of Ophthalmology Treatment
1.2 Classification of Ophthalmology Treatment by Type
1.2.1 Global Ophthalmology Treatment Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Ophthalmology Treatment Revenue Market Share by Type in 2019
1.2.3 Gels
1.2.4 Eye Solutions
1.2.5 Capsules & Tablets
1.2.6 Eye Drops
1.2.7 Ointments
1.3 Global Ophthalmology Treatment Market by Application
1.3.1 Overview: Global Ophthalmology Treatment Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital
1.3.3 Retail Pharmacy
1.4 Global Ophthalmology Treatment Market by Regions
1.4.1 Global Ophthalmology Treatment Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Ophthalmology Treatment (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Ophthalmology Treatment Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Ophthalmology Treatment Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Ophthalmology Treatment Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Ophthalmology Treatment Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Ophthalmology Treatment Status and Prospect (2015-2025)
2 Company Profiles
2.1 Allergan
2.1.1 Allergan Details
2.1.2 Allergan Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Allergan SWOT Analysis
2.1.4 Allergan Product and Services
2.1.5 Allergan Ophthalmology Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.2 Regeneron
2.2.1 Regeneron Details
2.2.2 Regeneron Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Regeneron SWOT Analysis
2.2.4 Regeneron Product and Services
2.2.5 Regeneron Ophthalmology Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.3 Valeant
2.3.1 Valeant Details
2.3.2 Valeant Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Valeant SWOT Analysis
2.3.4 Valeant Product and Services
2.3.5 Valeant Ophthalmology Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.4 Aerie Pharmaceuticals
2.4.1 Aerie Pharmaceuticals Details
2.4.2 Aerie Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Aerie Pharmaceuticals SWOT Analysis
2.4.4 Aerie Pharmaceuticals Product and Services
2.4.5 Aerie Pharmaceuticals Ophthalmology Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.5 Novartis
2.5.1 Novartis Details
2.5.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Novartis SWOT Analysis
2.5.4 Novartis Product and Services
2.5.5 Novartis Ophthalmology Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.6 Pfizer
2.6.1 Pfizer Details
2.6.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Pfizer SWOT Analysis
2.6.4 Pfizer Product and Services
2.6.5 Pfizer Ophthalmology Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.7 Santen Pharmaceutical
2.7.1 Santen Pharmaceutical Details
2.7.2 Santen Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Santen Pharmaceutical SWOT Analysis
2.7.4 Santen Pharmaceutical Product and Services
2.7.5 Santen Pharmaceutical Ophthalmology Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.8 Genentech
2.8.1 Genentech Details
2.8.2 Genentech Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Genentech SWOT Analysis
2.8.4 Genentech Product and Services
2.8.5 Genentech Ophthalmology Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.9 Bayer
2.9.1 Bayer Details
2.9.2 Bayer Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Bayer SWOT Analysis
2.9.4 Bayer Product and Services
2.9.5 Bayer Ophthalmology Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.10 Takeda
2.10.1 Takeda Details
2.10.2 Takeda Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Takeda SWOT Analysis
2.10.4 Takeda Product and Services
2.10.5 Takeda Ophthalmology Treatment Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Ophthalmology Treatment Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Ophthalmology Treatment Players Market Share
3.2.2 Top 10 Ophthalmology Treatment Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Ophthalmology Treatment Revenue and Market Share by Regions
4.2 North America Ophthalmology Treatment Revenue and Growth Rate (2015-2020)
4.3 Europe Ophthalmology Treatment Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Ophthalmology Treatment Revenue and Growth Rate (2015-2020)
4.5 South America Ophthalmology Treatment Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Ophthalmology Treatment Revenue and Growth Rate (2015-2020)
5 North America Ophthalmology Treatment Revenue by Countries
5.1 North America Ophthalmology Treatment Revenue by Countries (2015-2020)
5.2 USA Ophthalmology Treatment Revenue and Growth Rate (2015-2020)
5.3 Canada Ophthalmology Treatment Revenue and Growth Rate (2015-2020)
5.4 Mexico Ophthalmology Treatment Revenue and Growth Rate (2015-2020)
6 Europe Ophthalmology Treatment Revenue by Countries
6.1 Europe Ophthalmology Treatment Revenue by Countries (2015-2020)
6.2 Germany Ophthalmology Treatment Revenue and Growth Rate (2015-2020)
6.3 UK Ophthalmology Treatment Revenue and Growth Rate (2015-2020)
6.4 France Ophthalmology Treatment Revenue and Growth Rate (2015-2020)
6.5 Russia Ophthalmology Treatment Revenue and Growth Rate (2015-2020)
6.6 Italy Ophthalmology Treatment Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Ophthalmology Treatment Revenue by Countries
7.1 Asia-Pacific Ophthalmology Treatment Revenue by Countries (2015-2020)
7.2 China Ophthalmology Treatment Revenue and Growth Rate (2015-2020)
7.3 Japan Ophthalmology Treatment Revenue and Growth Rate (2015-2020)
7.4 Korea Ophthalmology Treatment Revenue and Growth Rate (2015-2020)
7.5 India Ophthalmology Treatment Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Ophthalmology Treatment Revenue and Growth Rate (2015-2020)
8 South America Ophthalmology Treatment Revenue by Countries
8.1 South America Ophthalmology Treatment Revenue by Countries (2015-2020)
8.2 Brazil Ophthalmology Treatment Revenue and Growth Rate (2015-2020)
8.3 Argentina Ophthalmology Treatment Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Ophthalmology Treatment by Countries
9.1 Middle East & Africa Ophthalmology Treatment Revenue by Countries (2015-2020)
9.2 Saudi Arabia Ophthalmology Treatment Revenue and Growth Rate (2015-2020)
9.3 UAE Ophthalmology Treatment Revenue and Growth Rate (2015-2020)
9.4 Egypt Ophthalmology Treatment Revenue and Growth Rate (2015-2020)
9.5 South Africa Ophthalmology Treatment Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Ophthalmology Treatment Revenue and Market Share by Type (2015-2020)
10.2 Global Ophthalmology Treatment Market Forecast by Type (2019-2024)
10.3 Gels Revenue Growth Rate (2015-2025)
10.4 Eye Solutions Revenue Growth Rate (2015-2025)
10.5 Capsules & Tablets Revenue Growth Rate (2015-2025)
10.6 Eye Drops Revenue Growth Rate (2015-2025)
10.7 Ointments Revenue Growth Rate (2015-2025)
11 Global Ophthalmology Treatment Market Segment by Application
11.1 Global Ophthalmology Treatment Revenue Market Share by Application (2015-2020)
11.2 Ophthalmology Treatment Market Forecast by Application (2019-2024)
11.3 Hospital Revenue Growth (2015-2020)
11.4 Retail Pharmacy Revenue Growth (2015-2020)
12 Global Ophthalmology Treatment Market Size Forecast (2021-2025)
12.1 Global Ophthalmology Treatment Market Size Forecast (2021-2025)
12.2 Global Ophthalmology Treatment Market Forecast by Regions (2021-2025)
12.3 North America Ophthalmology Treatment Revenue Market Forecast (2021-2025)
12.4 Europe Ophthalmology Treatment Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Ophthalmology Treatment Revenue Market Forecast (2021-2025)
12.6 South America Ophthalmology Treatment Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Ophthalmology Treatment Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Ophthalmology Treatment Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Ophthalmology Treatment by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Ophthalmology Treatment Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Ophthalmology Treatment Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Allergan Corporate Information, Location and Competitors
Table 6. Allergan Ophthalmology Treatment Major Business
Table 7. Allergan Ophthalmology Treatment Total Revenue (USD Million) (2017-2018)
Table 8. Allergan SWOT Analysis
Table 9. Allergan Ophthalmology Treatment Product and Solutions
Table 10. Allergan Ophthalmology Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Regeneron Corporate Information, Location and Competitors
Table 12. Regeneron Ophthalmology Treatment Major Business
Table 13. Regeneron Ophthalmology Treatment Total Revenue (USD Million) (2018-2019)
Table 14. Regeneron SWOT Analysis
Table 15. Regeneron Ophthalmology Treatment Product and Solutions
Table 16. Regeneron Ophthalmology Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Valeant Corporate Information, Location and Competitors
Table 18. Valeant Ophthalmology Treatment Major Business
Table 19. Valeant Ophthalmology Treatment Total Revenue (USD Million) (2017-2018)
Table 20. Valeant SWOT Analysis
Table 21. Valeant Ophthalmology Treatment Product and Solutions
Table 22. Valeant Ophthalmology Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Aerie Pharmaceuticals Corporate Information, Location and Competitors
Table 24. Aerie Pharmaceuticals Ophthalmology Treatment Major Business
Table 25. Aerie Pharmaceuticals Ophthalmology Treatment Total Revenue (USD Million) (2017-2018)
Table 26. Aerie Pharmaceuticals SWOT Analysis
Table 27. Aerie Pharmaceuticals Ophthalmology Treatment Product and Solutions
Table 28. Aerie Pharmaceuticals Ophthalmology Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Novartis Corporate Information, Location and Competitors
Table 30. Novartis Ophthalmology Treatment Major Business
Table 31. Novartis Ophthalmology Treatment Total Revenue (USD Million) (2017-2018)
Table 32. Novartis SWOT Analysis
Table 33. Novartis Ophthalmology Treatment Product and Solutions
Table 34. Novartis Ophthalmology Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Pfizer Corporate Information, Location and Competitors
Table 36. Pfizer Ophthalmology Treatment Major Business
Table 37. Pfizer Ophthalmology Treatment Total Revenue (USD Million) (2017-2018)
Table 38. Pfizer SWOT Analysis
Table 39. Pfizer Ophthalmology Treatment Product and Solutions
Table 40. Pfizer Ophthalmology Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Santen Pharmaceutical Corporate Information, Location and Competitors
Table 42. Santen Pharmaceutical Ophthalmology Treatment Major Business
Table 43. Santen Pharmaceutical Ophthalmology Treatment Total Revenue (USD Million) (2017-2018)
Table 44. Santen Pharmaceutical SWOT Analysis
Table 45. Santen Pharmaceutical Ophthalmology Treatment Product and Solutions
Table 46. Santen Pharmaceutical Ophthalmology Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Genentech Corporate Information, Location and Competitors
Table 48. Genentech Ophthalmology Treatment Major Business
Table 49. Genentech Ophthalmology Treatment Total Revenue (USD Million) (2017-2018)
Table 50. Genentech SWOT Analysis
Table 51. Genentech Ophthalmology Treatment Product and Solutions
Table 52. Genentech Ophthalmology Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Bayer Corporate Information, Location and Competitors
Table 54. Bayer Ophthalmology Treatment Major Business
Table 55. Bayer Ophthalmology Treatment Total Revenue (USD Million) (2017-2018)
Table 56. Bayer SWOT Analysis
Table 57. Bayer Ophthalmology Treatment Product and Solutions
Table 58. Bayer Ophthalmology Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Takeda Corporate Information, Location and Competitors
Table 60. Takeda Ophthalmology Treatment Major Business
Table 61. Takeda Ophthalmology Treatment Total Revenue (USD Million) (2017-2018)
Table 62. Takeda SWOT Analysis
Table 63. Takeda Ophthalmology Treatment Product and Solutions
Table 64. Takeda Ophthalmology Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Global Ophthalmology Treatment Revenue (Million USD) by Players (2015-2020)
Table 66. Global Ophthalmology Treatment Revenue Share by Players (2015-2020)
Table 67. Global Ophthalmology Treatment Revenue (Million USD) by Regions (2015-2020)
Table 68. Global Ophthalmology Treatment Revenue Market Share by Regions (2015-2020)
Table 69. North America Ophthalmology Treatment Revenue by Countries (2015-2020)
Table 70. North America Ophthalmology Treatment Revenue Market Share by Countries (2015-2020)
Table 71. Europe Ophthalmology Treatment Revenue (Million USD) by Countries (2015-2020)
Table 72. Asia-Pacific Ophthalmology Treatment Revenue (Million USD) by Countries (2015-2020)
Table 73. South America Ophthalmology Treatment Revenue by Countries (2015-2020)
Table 74. South America Ophthalmology Treatment Revenue Market Share by Countries (2015-2020)
Table 75. Middle East and Africa Ophthalmology Treatment Revenue (Million USD) by Countries (2015-2020)
Table 76. Middle East and Africa Ophthalmology Treatment Revenue Market Share by Countries (2015-2020)
Table 77. Global Ophthalmology Treatment Revenue (Million USD) by Type (2015-2020)
Table 78. Global Ophthalmology Treatment Revenue Share by Type (2015-2020)
Table 79. Global Ophthalmology Treatment Revenue Forecast by Type (2021-2025)
Table 80. Global Ophthalmology Treatment Revenue by Application (2015-2020)
Table 81. Global Ophthalmology Treatment Revenue Share by Application (2015-2020)
Table 82. Global Ophthalmology Treatment Revenue Forecast by Application (2021-2025)
Table 83. Global Ophthalmology Treatment Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Ophthalmology Treatment Picture
Figure 2. Global Ophthalmology Treatment Revenue Market Share by Type in 2019
Figure 3. Gels Picture
Figure 4. Eye Solutions Picture
Figure 5. Capsules & Tablets Picture
Figure 6. Eye Drops Picture
Figure 7. Ointments Picture
Figure 8. Ophthalmology Treatment Revenue Market Share by Application in 2019
Figure 9. Hospital Picture
Figure 10. Retail Pharmacy Picture
Figure 11. Global Ophthalmology Treatment Revenue (USD Million) and Growth Rate (2015-2025)
Figure 12. North America Ophthalmology Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Europe Ophthalmology Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Asia-Pacific Ophthalmology Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. South America Ophthalmology Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Middle East and Africa Ophthalmology Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Global Ophthalmology Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Global Ophthalmology Treatment Revenue Share by Players in 2019
Figure 19. Global Top 5 Players Ophthalmology Treatment Revenue Market Share in 2019
Figure 20. Global Top 10 Players Ophthalmology Treatment Revenue Market Share in 2019
Figure 21. Key Players Market Share Trend
Figure 22. Global Ophthalmology Treatment Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 23. Global Ophthalmology Treatment Revenue Market Share by Regions (2015-2020)
Figure 24. Global Ophthalmology Treatment Revenue Market Share by Regions in 2018
Figure 25. North America Ophthalmology Treatment Revenue and Growth Rate (2015-2020)
Figure 26. Europe Ophthalmology Treatment Revenue and Growth Rate (2015-2020)
Figure 27. Asia-Pacific Ophthalmology Treatment Revenue and Growth Rate (2015-2020)
Figure 28. South America Ophthalmology Treatment Revenue and Growth Rate (2015-2020)
Figure 29. Middle East and Africa Ophthalmology Treatment Revenue and Growth Rate (2015-2020)
Figure 30. North America Ophthalmology Treatment Revenue Market Share by Countries (2015-2020)
Figure 31. North America Ophthalmology Treatment Revenue Market Share by Countries in 2019
Figure 32. USA Ophthalmology Treatment Revenue and Growth Rate (2015-2020)
Figure 33. Canada Ophthalmology Treatment Revenue and Growth Rate (2015-2020)
Figure 34. Mexico Ophthalmology Treatment Revenue and Growth Rate (2015-2020)
Figure 35. Europe Ophthalmology Treatment Revenue Market Share by Countries (2015-2020)
Figure 36. Europe Ophthalmology Treatment Revenue Market Share by Countries in 2019
Figure 37. Germany Ophthalmology Treatment Revenue and Growth Rate (2015-2020)
Figure 38. UK Ophthalmology Treatment Revenue and Growth Rate (2015-2020)
Figure 39. France Ophthalmology Treatment Revenue and Growth Rate (2015-2020)
Figure 40. Russia Ophthalmology Treatment Revenue and Growth Rate (2015-2020)
Figure 41. Italy Ophthalmology Treatment Revenue and Growth Rate (2015-2020)
Figure 42. Asia-Pacific Ophthalmology Treatment Revenue Market Share by Countries (2015-2020)
Figure 43. Asia-Pacific Ophthalmology Treatment Revenue Market Share by Countries in 2019
Figure 44. China Ophthalmology Treatment Revenue and Growth Rate (2015-2020)
Figure 45. Japan Ophthalmology Treatment Revenue and Growth Rate (2015-2020)
Figure 46. Korea Ophthalmology Treatment Revenue and Growth Rate (2015-2020)
Figure 47. India Ophthalmology Treatment Revenue and Growth Rate (2015-2020)
Figure 48. Southeast Asia Ophthalmology Treatment Revenue and Growth Rate (2015-2020)
Figure 49. South America Ophthalmology Treatment Revenue Market Share by Countries (2015-2020)
Figure 50. South America Ophthalmology Treatment Revenue Market Share by Countries in 2019
Figure 51. Brazil Ophthalmology Treatment Revenue and Growth Rate (2015-2020)
Figure 52. Argentina Ophthalmology Treatment Revenue and Growth Rate (2015-2020)
Figure 53. Middle East and Africa Ophthalmology Treatment Revenue Market Share by Countries (2015-2020)
Figure 54. Middle East and Africa Ophthalmology Treatment Revenue Market Share by Countries in 2019
Figure 55. Saudi Arabia Ophthalmology Treatment Revenue and Growth Rate (2015-2020)
Figure 56. UAE Ophthalmology Treatment Revenue and Growth Rate (2015-2020)
Figure 57. Egypt Ophthalmology Treatment Revenue and Growth Rate (2015-2020)
Figure 58. South Africa Ophthalmology Treatment Revenue and Growth Rate (2015-2020)
Figure 59. Global Ophthalmology Treatment Revenue Share by Type (2015-2020)
Figure 60. Global Ophthalmology Treatment Revenue Share by Type in 2019
Figure 61. Global Ophthalmology Treatment Market Share Forecast by Type (2021-2025)
Figure 62. Global Gels Revenue Growth Rate (2015-2020)
Figure 63. Global Eye Solutions Revenue Growth Rate (2015-2020)
Figure 64. Global Capsules & Tablets Revenue Growth Rate (2015-2020)
Figure 65. Global Eye Drops Revenue Growth Rate (2015-2020)
Figure 66. Global Ointments Revenue Growth Rate (2015-2020)
Figure 67. Global Ophthalmology Treatment Revenue Share by Application (2015-2020)
Figure 68. Global Ophthalmology Treatment Revenue Share by Application in 2019
Figure 69. Global Ophthalmology Treatment Market Share Forecast by Application (2021-2025)
Figure 70. Global Hospital Revenue Growth Rate (2015-2020)
Figure 71. Global Retail Pharmacy Revenue Growth Rate (2015-2020)
Figure 72. Global Ophthalmology Treatment Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 73. Global Ophthalmology Treatment Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 74. Global Ophthalmology Treatment Revenue Market Share Forecast by Regions (2021-2025)
Figure 75. North America Ophthalmology Treatment Revenue Market Forecast (2021-2025)
Figure 76. Europe Ophthalmology Treatment Revenue Market Forecast (2021-2025)
Figure 77. Asia-Pacific Ophthalmology Treatment Revenue Market Forecast (2021-2025)
Figure 78. South America Ophthalmology Treatment Revenue Market Forecast (2021-2025)
Figure 79. Middle East and Africa Ophthalmology Treatment Revenue Market Forecast (2021-2025)
Figure 80. Sales Channel: Direct Channel vs Indirect Channel
眼科薬の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Ophthalmology Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Ophthalmology Drugs marke…- 眼科用PACS（画像アーカイブ・通信システム）の世界市場（～2026年） Ophthalmology PACS are used in the efficient management of image data eliminating the physical constraints associated with communication of radiologic image data on film. The market is dominated by North America, followed by Europe. The dominance of the North American market is attributed to factors…
- 眼科用機器の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Ophthalmology Instrumentation market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Ophthalmology I…
- 目感染症治療の世界市場（～2026年） Eye infections can be the inflammation of the Conjunctiva (Conjunctivitis), eyelid (blepharitis), the cornea (keratitis), the liquid inside the eye (vitritis), the retina and the blood vessels that feed it (chorioretinitis), or the optic nerve (neuroretinitis). Eye infections treatment market is gro…
- サイトメガロウイルス（CMV）網膜炎治療の世界市場（～2026年） Ophthalmology is the branch of medical science that deals with the management and study of anatomy, physiology, and diseases related to the human eye. Globally, the incidence of eye disorders and vision loss are becoming major public health issues. Some of the major eye diseases include age-related …